ALLMedicine™ Trigeminal Neuralgia Center
Research & Reviews 1,093 results
https://doi.org/10.1111/head.14321
Headache Munoz A, Maxwell C et. al.
May 21st, 2022 - The objective of this paper is to present a narrative review of the use of triptans in the treatment of trigeminal neuralgia (TN), as well as to outline possible therapeutic mechanisms of action. TN is a debilitating neuropathic disorder with a va...
https://clinicaltrials.gov/ct2/show/NCT03941834
May 20th, 2022 - The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater reduction in the average Numeric Pain Rating Scale between the two...
https://doi.org/10.1016/j.wneu.2022.05.010
World Neurosurgery; Bonaudo C, Esposito A et. al.
May 15th, 2022 - Surgical resolution of trigeminal neuralgia complicating vestibular schwannoma removal.|2022|Bonaudo C,Esposito A,Spalletti M,Pecchioli G,Trabalzini F,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080139
Journal of Medical Case Reports; Aghamohammadi D, Sharifi S et. al.
May 8th, 2022 - Despite some advances, treatment of trigeminal neuralgia remains a significant challenge. This study determines the efficacy and safety of autologous conditioned serum (Orthokine) injection into the foramen oval to treat refractory trigeminal neur...
https://doi.org/10.1111/head.14316
Headache Dominguez M, Di Stefano G
May 8th, 2022 - Novel ways of approaching the pharmacologic treatment of trigeminal neuralgia.|2022|Dominguez M,Di Stefano G,|
Guidelines 2 results
https://doi.org/10.1093/neuros/nyx512
Neurosurgery Hadjipanayis CG, Carlson ML et. al.
Jan 9th, 2018 - What surgical approaches for vestibular schwannomas (VS) are best for complete resection and facial nerve (FN) preservation when serviceable hearing is present? There is insufficient evidence to support the superiority of either the middle fossa (...
https://doi.org/10.1111/j.1533-2500.2009.00298.x
Pain Practice : the Official Journal of World Institute O... van Kleef M, van Genderen WE et. al.
Jul 22nd, 2009 - Trigeminal neuralgia is a common cause of facial pain. It has a significant impact on the quality of life and the socioeconomic functioning of the patient. The aim of this review is to provide recommendations for medical management of trigeminal n...
Drugs 43 results see all →
Clinicaltrials.gov 35 results
https://clinicaltrials.gov/ct2/show/NCT03941834
May 20th, 2022 - The purpose of this study is to evaluate the efficacy of BHV3000 compared to placebo for subjects with treatment refractory Trigeminal Neuralgia as measured by a 2-point or greater reduction in the average Numeric Pain Rating Scale between the two...
https://clinicaltrials.gov/ct2/show/NCT05142228
May 6th, 2022 - TNP are a considerable burden and affects significantly the quality of life of the sufferer. There are medications for their management but while they may work for some patients, may not work for the others; in addition, side effects may be presen...
https://clinicaltrials.gov/ct2/show/NCT03712254
Mar 24th, 2022 - The nature of trigeminal neuralgia (TN) is fluctuating and patients can experience periods of complete remission of pain as well as periods with excessive pain. TN is often triggered by innocuous intra- and extraoral stimuli such as chewing. Since...
https://clinicaltrials.gov/ct2/show/NCT04579692
Mar 21st, 2022 - The purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it aff...
https://clinicaltrials.gov/ct2/show/NCT04272385
Feb 21st, 2022 - Trigeminal Neuralgia (TN) is a rare chronic condition that causes agonizing, unpredictable, short-lasting electric shock-like one-sided facial pain and is commonly provoked by triggers such as light touch. This debilitating chronic pain disorder h...
News 32 results
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM
Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.
https://www.medscape.com/viewarticle/962892
Nov 12th, 2021 - NEW ORLEANS — Intraorbital frontal nerve resection appears effective for some patients with idiopathic trigeminal neuralgia where the ophthalmic division (V1) is involved, researchers say. The procedure offers long-term relief in a condition where...
https://www.medscape.com/viewarticle/938374
Oct 1st, 2020 - The National Institute for Health and Care Excellence (NICE) has published updated recommendations on the management of neuropathic pain. Key recommendations are summarised below: Principles of care When agreeing a treatment plan with the person d...
https://www.staging.medscape.com/viewarticle/928157
Apr 5th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Since the Centers for Disease Control and Prevention (CDC) confirmed the first US case of novel coronavirus infection on January 20, much of the ...
https://reference.medscape.com/viewarticle/927392
Mar 27th, 2020 - Lesions or diseases of the somatosensory nervous system cause neuropathic pain. Instead of being used to sense touch, pressure, temperature, position, movement, and vibration, the patient perceives chronic or intermittent paresthesia and locally a...